Stony Brook Medicine is the first on Long Island — and one of a select number of healthcare systems nationwide — to implement an artificial intelligence (AI) technology, HeartFlow Plaque Analysis™, to enable its physicians to more accurately understand the blockages present in the coronary arteries of patients with suspected heart disease. This advancement, introduced at Stony Brook through a collaboration by the Division of Cardiology and the Department of Radiology, represents a significant milestone in the fight against heart disease, which remains the leading cause of death for adults in the United States.